Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

DF Florescu, MA Keck - Expert review of anti-infective therapy, 2014 - Taylor & Francis
CMX001 (hexadecyloxypropyl-cidofovir, Brincidofovir) is a broad spectrum, lipid conjugate
of cidofovir that is converted intracellularly into the active antiviral, cidofovir diphosphate …

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

DF Florescu, MA Keck - Expert review of anti-infective …, 2014 - pubmed.ncbi.nlm.nih.gov
CMX001 (hexadecyloxypropyl-cidofovir, Brincidofovir) is a broad spectrum, lipid conjugate
of cidofovir that is converted intracellularly into the active antiviral, cidofovir diphosphate …

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.

DF Florescu, MA Keck - 2014 - cabidigitallibrary.org
Abstract CMX001 (hexadecyloxypropyl-cidofovir, Brincidofovir) is a broad spectrum, lipid
conjugate of cidofovir that is converted intracellularly into the active antiviral, cidofovir …

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.

DF Florescu, MA Keck - Expert Review of Anti-infective Therapy, 2014 - europepmc.org
CMX001 (hexadecyloxypropyl-cidofovir, Brincidofovir) is a broad spectrum, lipid conjugate
of cidofovir that is converted intracellularly into the active antiviral, cidofovir diphosphate …

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

DF Florescu, MA Keck - Expert Review of Anti-Infective …, 2014 - experts.nebraska.edu
Abstract CMX001 (hexadecyloxypropyl-cidofovir, Brincidofovir) is a broad spectrum, lipid
conjugate of cidofovir that is converted intracellularly into the active antiviral, cidofovir …